胰腺癌的边界是生物标志物,微环境和免疫治疗
Baofa Yu1, Shengwen Shao2, Wenxue Ma3
1Taimei Baofa Cancer Hospital, Dongping, Shandong, 271500, China; Jinan Baofa Cancer Hospital, Jinan, Shandong, 250000, China; Beijing Baofa Cancer Hospital, Beijing, 100010, China; Immune Oncology Systems, Inc, San Diego, CA, 92102, USA.
Cancer letters
|November 24, 2024
概括
胰腺癌研究推进了使用微RNA (miRNA) 和循环瘤DNA (ctDNA) 等生物标志物的早期检测. 新疗法针对瘤微环境 (TME) 并使用人工智能 (AI) 进行个性化治疗.
科学领域:
- 在瘤学瘤学.
- 生物标志物发现发现
- 人工智能在医学中的应用
背景情况:
- 胰腺癌由于晚期诊断和治疗阻力而带来了重大治疗挑战.
- 现有的治疗方法通常受到疾病的攻击性和复杂的瘤微环境 (TME) 的限制.
研究的目的:
- 审查胰腺癌早期检测和治疗策略的最新进展.
- 探索新型生物标志物,TME调制和人工智能 (AI) 在改善患者治疗结果中的作用.
主要方法:
- 综合性文献综述,重点关注新兴生物标记物 (miRNAs,ctDNA),TME组件 (CAFs,免疫细胞,ECM) 和人工智能应用.
- 分析多主题数据集成,以提高诊断灵敏度和个性化治疗计划.
主要成果:
- 微RNAs (miRNAs) 和循环瘤DNA (ctDNA) 在与多组组合时显示出对敏感早期诊断的承诺.
- 包括癌症相关纤维细胞 (CAF) 和细胞外基质 (ECM) 在内的TME显著促进治疗耐药性.
- 人工智能有助于解释复杂的数据,从而实现个性化的治疗策略和响应监测.
结论:
- 结合新型生物标志物,TME向疗法和AI的综合方法对于推进胰腺癌治疗至关重要.
- 未来的研究应该优先考虑生物标志物的临床验证,人工智能监管框架和公平获得创新疗法.
相关概念视频
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
01:27Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K